ICAM1 can also regulate immune cell-mediated tumor cytotoxicity, thereby improving the prognosis of patients with certain tumors, such as melanoma and oral squamous cell carcinoma (26). This evidence concerns the gene ICAM1 and oral cavity squamous cell carcinoma.